BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37679007)

  • 21. Mosaic 46,XY,dup(14) (q12q22.3)/46, XY at amniocentesis in a pregnancy associated with a favorable fetal outcome and cytogenetic discrepancy in various tissues.
    Chen CP; Wu FT; Chen CY; Chen SW; Chern SR; Wu PS; Pan YT; Lee CC; Lee MS; Chen YY; Wang W
    Taiwan J Obstet Gynecol; 2023 Mar; 62(2):343-347. PubMed ID: 36965906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-level mosaic trisomy 9 at amniocentesis associated with a positive non-invasive prenatal testing for trisomy 9, maternal uniparental disomy 9, intrauterine growth restriction and a favorable fetal outcome in a pregnancy.
    Chen CP; Ko TM; Chen SW; Chern SR; Wu FT; Pan YT; Pan CW; Chen YY; Wang W
    Taiwan J Obstet Gynecol; 2023 May; 62(3):457-460. PubMed ID: 37188454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetic discrepancy between uncultured amniocytes and cultured amniocytes in mosaic trisomy 15 at amniocentesis in a pregnancy with a favorable outcome.
    Chen CP; Ko TM; Chen TC; Chern SR; Wu PS; Chen SW; Wu FT; Chen WL; Chen YY; Wang W
    Taiwan J Obstet Gynecol; 2022 Jul; 61(4):677-683. PubMed ID: 35779921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mosaic trisomy 16 at amniocentesis in a pregnancy associated with positive non-invasive prenatal testing for trisomy 16, placental trisomy 16, intrauterine growth restriction, intrauterine fetal death, cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes, and prenatal progressive decrease of the aneuploid cell line.
    Chen CP; Wu FT; Chen YY; Pan YT; Wu PS; Lee MS; Pan CW; Wang W
    Taiwan J Obstet Gynecol; 2023 Jul; 62(4):597-601. PubMed ID: 37407203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-level mosaic trisomy 21 at amniocentesis in a pregnancy associated with positive NIPT for trisomy 21, prenatal progressive decrease of the trisomy 21 cell line, acute fatty liver of pregnancy and intrauterine fetal death in late gestation.
    Chen CP; Wang LK; Wu FT; Pan YT; Wu PS; Chen WL; Lee MS; Wang W
    Taiwan J Obstet Gynecol; 2023 Nov; 62(6):896-900. PubMed ID: 38008511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mosaic 46,XY,der(15)t(6;15)(q25.1;p12)/46,XY at amniocentesis in a pregnancy associated with a favorable fetal outcome and postnatal decrease of the aneuploid cell line with the unbalanced translocation.
    Chen CP; Chen SW; Chen YY; Chern SR; Wu PS; Wu FT; Pan YT; Lee CC; Chen YY; Wang W
    Taiwan J Obstet Gynecol; 2023 Jan; 62(1):142-147. PubMed ID: 36720528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal diagnosis of mosaicism for double aneuploidy of 47,XXY and trisomy 7 (48,XXY,+7) at amniocentesis in a pregnancy with a favorable outcome.
    Chen CP; Tsai HT; Chern SR; Wu PS; Chen SW; Wu FT; Chen YY; Town DD; Chen WL; Lee MS; Wang W
    Taiwan J Obstet Gynecol; 2021 May; 60(3):543-548. PubMed ID: 33966745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes in mosaic trisomy 20 at amniocentesis in a pregnancy with a favorable outcome.
    Chen CP; Lin YH; Wu PS; Chern SR; Chen SW; Wu FT; Lee CC; Pan CW; Chen YY; Wang W
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):138-140. PubMed ID: 35181025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive increase of the mosaic level for 45,X in 45,X/46, XX at different amniocenteses and postnatal progressive decrease of the 45,X cell line in a mosaic 45,X/46, XX fetus with a favorable outcome.
    Chen CP; Chern SR; Chen SW; Wu FT; Lee CC; Chen WL; Chen YY; Wang W
    Taiwan J Obstet Gynecol; 2022 Sep; 61(5):876-879. PubMed ID: 36088060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-level mosaic trisomy 21 at amniocentesis in a pregnancy associated with cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes, perinatal progressive decrease of the aneuploid cell line and a favorable fetal outcome.
    Chen CP; Wu FT; Pan YT; Wu PS; Pan CW; Wang W
    Taiwan J Obstet Gynecol; 2023 Nov; 62(6):910-914. PubMed ID: 38008514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mosaicism for a 12p12.1p12.2 microdeletion with a normal euploid cell line at amniocentesis in a pregnancy with a favorable outcome and postnatal decrease of the aneuploid cell line with microdeletion.
    Chen CP; Wu FT; Pan YT; Wu PS; Wang W
    Taiwan J Obstet Gynecol; 2023 Sep; 62(5):757-760. PubMed ID: 37679009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mosaicism for a 15q11.2 microduplication with a normal euploid cell line at amniocentesis in a pregnancy with a favorable fetal outcome and postnatal decrease of the aneuploid cell line with the microduplication.
    Chen CP; Wu FT; Pan YT; Wu PS; Wang W
    Taiwan J Obstet Gynecol; 2023 Jul; 62(4):602-605. PubMed ID: 37407204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mosaic trisomy 21 at amniocentesis in a twin pregnancy associated with a favorable fetal outcome, maternal uniparental disomy 21 and postnatal decrease of the trisomy 21 cell line.
    Chen CP; Hsu TY; Chern SR; Wu PS; Chen SW; Wang LK; Wu FT; Pan YT; Lee CC; Chen YY; Wang W
    Taiwan J Obstet Gynecol; 2023 Jan; 62(1):137-141. PubMed ID: 36720527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes in mosaic 46,XX,dup(9)(q22.3q34.1)/46,XX at amniocentesis in a pregnancy with a favorable outcome.
    Chen CP; Su JW; Chern SR; Wu PS; Chen SW; Wu FT; Chen YY; Chen WL; Lee MS; Pan CW; Wang W
    Taiwan J Obstet Gynecol; 2022 Mar; 61(2):368-371. PubMed ID: 35361404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytogenetic discrepancy between uncultured amniocytes and cultured amniocytes in mosaic trisomy 15 at amniocentesis.
    Chen CP; Hsu TY; Ko TM; Chern SR; Wu PS; Chen SW; Wu FT; Chen YY; Lee CC; Pan CW; Wang W
    Taiwan J Obstet Gynecol; 2020 Sep; 59(5):728-735. PubMed ID: 32917326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mosaic trisomy 18 at amniocentesis associated with a favorable fetal outcome in a pregnancy.
    Chen CP; Hsu TY; Tsai CC; Chern SR; Chen SW; Wu FT; Wu PS; Lee CC; Chen LF; Pan CW; Wang W
    Taiwan J Obstet Gynecol; 2022 Jul; 61(4):690-694. PubMed ID: 35779923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 45,X/46,XX at amniocentesis associated with cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes and in different amniocenteses and a favorable fetal outcome with a normal karyotype at birth.
    Chen CP; Wu FT; Pan YT; Wu PS; Wang W
    Taiwan J Obstet Gynecol; 2023 Jul; 62(4):586-587. PubMed ID: 37407200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal diagnosis of pseudomosaicism for trisomy 20 at amniocentesis with a negative non-invasive prenatal testing (NIPT) result in a pregnancy with a favorable outcome.
    Chen CP; Wang LK; Chern SR; Wu PS; Chen SW; Wu FT; Chen YY; Pan CW; Wang W
    Taiwan J Obstet Gynecol; 2022 Jul; 61(4):675-676. PubMed ID: 35779920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mosaic trisomy 21 at amniocentesis associated with a favorable fetal outcome and perinatal progressive decrease of the trisomy 21 cell line.
    Chen CP; Chen SW; Wang LK; Chern SR; Wu PS; Wu FT; Pan YT; Lee CC; Chen LF; Pan CW; Chen YY; Wang W
    Taiwan J Obstet Gynecol; 2023 Jan; 62(1):132-136. PubMed ID: 36720526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-level mosaic trisomy 20 without uniparental disomy 20 at amniocentesis in a pregnancy associated with a favorable outcome, cytogenetic discrepancy between uncultured amniocytes and cultured amniocytes and perinatal progressive decrease of the aneuploid cell line.
    Chen CP; Wu FT; Pan YT; Chern SR; Wu PS; Lee CC; Wang W
    Taiwan J Obstet Gynecol; 2023 May; 62(3):466-469. PubMed ID: 37188456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.